60
Participants
Start Date
April 30, 2025
Primary Completion Date
April 30, 2027
Study Completion Date
April 30, 2027
Ketogenic diet
Ketogenic Diet as an Adjunct to Immunotherapy: Unlike many trials focused on chemotherapy or targeted therapies, this study specifically investigates the synergistic effects of the ketogenic diet with immune checkpoint inhibitors (ICIs), a promising approach for enhancing immunotherapy efficacy. The diet's high-fat, low-carbohydrate regimen is designed to shift metabolism towards ketone bodies and fatty acid utilization, potentially modulating immune responses and tumor immunogenicity in a way that standard diets do not.
Rabin Medical Center, Petah Tikva
Rabin Medical Center
OTHER